Sfoglia per AUTORE
RICCO A
Collezione AOU Novara

  

Items : 7

Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes. in Annals of hematology / Ann Hematol. 2024 Feb;103(2):437-442. doi: 10.1007/s00277-023-05577-9. Epub 2023 Dec 7.

2024
AOU Novara
AOU Città della Salute di Torino

Bellini M; Finazzi MC; Rambaldi A; Tognoni G; Cattaneo D; Vianelli N; Scaffidi L; Bucelli C; Lunghi F; Ramundo F; Betti S; Gesullo F; Guglielmelli P; Calabresi L; Loscocco GG; Cacciola E; Cascavilla N; Mora B; Rumi E; Patriarca A; Siragusa S; Rapezzi D; Musolino C; Caramella M; Pane F; Ricco A; Carli G; Palandri F; Benevolo G; et alii...

Health-related Quality of Life Profile of Newly Diagnosed Patients With Myelodysplastic Syndromes by Age, Sex, and Risk Group: A Real-world Study by the GIMEMA. in HemaSphere / Hemasphere. 2023 Aug 30;7(9):e944. doi: 10.1097/HS9.0000000000000944. eCollection 2023 Sep.

2023
AOU Novara
AOU Città della Salute di Torino

Vallisa D; Invernizzi R; Lemoli RM; Fedele M; Sarlo C; Capodanno I; Frairia C; Fianchi L; Voso MT; Baron F; Petranovic D; Ricco A; Stauder R; Luppi M; Breccia M; Cottone F; Caocci G; Palumbo GA; Niscola P; Platzbecker U; Al Essa W; Efficace F; Di Renzo N; Fozza C; Doro M; Giesinger JM; Vignetti M;

Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS). in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2023 Oct 1;41(28):4486-4496. doi: 10.1200/JCO.22.02699. Epub 2023 Jun 9.

2023
ASL Biella
AOU Città della Salute di Torino
AOU Novara
AO Alessandria

Latagliata R; Zini G; Rizzo L; Bova I; D'Errigo MG; Cufari P; Arcadi MT; Delfino IM; Liberati AM; Candoni A; Rivellini F; Buccisano F; Stamatoullas-Bastard A; Ricco A; Palumbo GA; Impera S; Di Renzo N; Fenaux P; Germing U; Molteni A; Bocchia M; Beltrami G; Russo E; Castelli A; Fattizzo B; Guarini A; Tripepi G; Iannì G; Reda G; et alii...

Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial. in The Lancet. Haematology / Lancet Haematol. 2021 Mar;8(3):e175-e184. doi: 10.1016/S2352-3026(20)30373-2. Epub 2021 Jan 18.

2021
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Tognoni G; Finazzi MC; Bellini M; Bucelli C; Lunghi F; Vianelli N; Scaffidi L; Betti S; Guglielmelli P; Loscocco GG; Mora B; Cacciola E; Mannarelli C; Patriarca A; Cascavilla N; Rumi E; Siragusa S; Musolino C; Caramella M; Rapezzi D; Ricco A; Carli G; Palandri F; Pane F; Benevolo G; Bonifacio M; Iurlo A; Ciceri F; Ghirardi A; et alii...

The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS index. in Leukemia / Leukemia. 2020 Sep;34(9):2451-2459. doi: 10.1038/s41375-020-0746-8. Epub 2020 Feb 21.

2020
AOU Città della Salute di Torino
AOU Novara

Capodanno I; Frairia C; Fianchi L; Luppi M; Petranovic D; Caers J; Ricco A; Stauder R; Caocci G; Palumbo GA; Platzbecker U; Breccia M; Niscola P; Patriarca A; Cella D; Oswald LB; Cottone F; Efficace F; Follini E; Sarlo C; Fazi P; Vignetti M;

Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study. in The Lancet. Oncology / Lancet Oncol. 2015 Nov;16(15):1506-1514. doi: 10.1016/S1470-2045(15)00206-5. Epub 2015 Sep 21.

2015
AOU Novara

Efficace F; Gaidano G; Breccia M; Voso MT; Cottone F; Angelucci E; Caocci G; Stauder R; Selleslag D; Sprangers M; Platzbecker U; Ricco A; Sanpaolo G; Beyne-Rauzy O; Buccisano F; Palumbo GA; Bowen D; Nguyen K; Niscola P; Vignetti M; Mandelli F;

Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes. in Leukemia research / Leuk Res. 2015 Aug;39(8):859-65. doi: 10.1016/j.leukres.2015.05.012. Epub 2015 Jun 12.

2015
AOU Novara

Caocci G; Voso MT; Angelucci E; Stauder R; Cottone F; Abel G; Nguyen K; Platzbecker U; Beyne-Rauzy O; Gaidano G; Invernizzi R; Molica S; Criscuolo M; Breccia M; Lübbert M; Sanpaolo G; Buccisano F; Ricco A; Palumbo GA; Niscola P; Zhang H; Fenu S; La Nasa G; Mandelli F; Efficace F;